Drug Compound Leads to Death of Ovarian Cancer Cells Resistant to Chemotherapy
Gil Mor In a discovery that may be useful for maintaining remission in chemo-resistant ovarian cancer, Yale scientists report that pre-clinical studies have shown the drug compound NV-128 can induce the death of ovarian cancer cells by halting the activation of a protein pathway called mTOR.
1 min read
